Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
LIXT
#3737
Lixte Biotechnology Holdings, Inc. Common Stock
2.9
0
-2.68%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-2.68%
Monthly Change
-15.20%
6 month change
-15.20%
Cambio anual
+110.14%
Cierres anteriores
2.9
8
Open
2.8
9
Bid
Ask
Low
2.8
5
High
2.9
4
Volumen
20
Markets
Acciones
Atención Sanitaria
LIXT
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
1.35 M
1.37 M
1.67 M
2.25 M
2.68 M
—
Valuation ratios
Enterprise value
—
—
—
4.45 M
7.91 M
45.66 M
Price to earnings ratio
—
—
—
-0.86
-1.28
-7.08
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
-1.02
-1.44
-9.3
Price to book ratio
—
—
—
8.87
-1.71
-5.68
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.62
-1.32
-1.14
-1.18
-3.13
-2.02
Return on equity %
0.65
-1.4
-1.22
-1.27
-4.33
-2.95
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
24.15
16.81
14.08
13.73
3.6
17.65
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
0
0
0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-2.92
-2.24
-1.41
-0.93
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
—
—
3.38
2.19
0.46
1.77
Net current asset value per share
—
—
3.51
2.25
0.51
2.58
Tangible book value per share
—
—
1.05
0.26
-1.19
-1.26
Working capital per share
—
—
3.26
2.09
0.37
1.95
Book value per share
—
—
1.05
0.26
-1.19
-1.26
Noticias
LIXTE Biotechnology nombra a Sidney Braun para liderar la filial Liora
LIXTE Biotechnology nombra a Sidney Braun para dirigir Liora
LIXTE Biotechnology appoints Sidney Braun to lead Liora subsidiary
LIXTE amplía ensayo clínico para tratamiento de cáncer de ovario
LIXTE expands clinical trial for ovarian cancer treatment
Las acciones de Lixte Biotechnology caen tras una oferta directa de 4,3 millones de dólares
Acciones de Lixte Biotechnology caen tras oferta directa de $4.3 millones
Spartan Capital actúa como agente en oferta de $4.3 mil millones de Lixte
Spartan Capital actúa como agente de colocación en oferta de 4,3 millones de dólares de Lixte
Lixte Biotechnology stock falls after $4.3 million direct offering
Spartan Capital acts as placement agent in Lixte’s $4.3 million offering
La acción de Lixte Biotechnology cae tras oferta directa de 4,3 millones de dólares